The Division of Neurosurgery will become the Department on Oct. 1, 2013, elevating the profile of an already world-renowned program.
Work may provide insight into drug design for autism, movement disorders.
The joint department formalizes a collaboration that began in 2009 when UAB created an undergraduate program in neuroscience.
The book addresses molecular, cellular, behavioral and clinical roles for epigenetic mechanisms in the nervous system
Founder Mike Jezdimir believes the foundation will have a profound effect on better understanding of TM and potential therapies for the disease.
UAB researchers have identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson’s disease.